tiprankstipranks
Trending News
More News >

ALX Oncology price target lowered to $1 from $1.20 at UBS

UBS lowered the firm’s price target on ALX Oncology (ALXO) to $1 from $1.20 and keeps a Buy rating on the shares.

Don’t Miss TipRanks’ Half Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1